Previous studies have found that in RA patients (48), SPP1 can interact with IFN-γ, enhance Th1 inflammatory response, and inhibit immune tolerance; synergize with RANKL, promote osteoclast differentiation and lead to bone erosion. This evidence concerns the gene SPP1 and rheumatoid arthritis.